Acne is one of the most common skin problems in the United States, and scarring from it can stick with you for the rest of your life … unless you use SkinPen® – the first microneedling device cleared by the Food and Drug Administration.1 

Learn all this and more in a short news segment recently featured on Twin Cities Live. Haley Fee of Bellus Medical partners with Simonson’s Salon and Spa, located in Minneapolis, Minnesota, to show viewers SkinPen in action. 

Fee walks through the entire microneedling process, including cleansing and comfortably numbing the skin, the use of SkinPen during the treatment, and post procedure expectations.  

SkinPen creates controlled micro-injuries that aren’t visible to the human eye. These stimulate the body’s natural wound-healing process, while minimizing cellular damage.  

The result? Effective remodeling of scar tissue, while keeping the overall structure of the skin intact. With little downtime, the procedures will help reduce the appearance of facial acne scars and help patients to feel more confident. SkinPen has been clinically proven to be safe for skin types ranging from fair to very dark for any one ages 22 and up. 

With 90% of subjects in a clinical trial saying they would recommend the treatment to friends and family, we feel confident that your practice will love SkinPen as well.  

Watch the segment to learn more.  

See intended use, important safety information, and clinical trial details (data on file) at